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plans were automatically generated for each patient, one for 
CK with 3 mm PTV margin, and two for VMAT with 3 and 5 
mm PTV margin, respectively. 
 
Results: With automated planning, high quality CK and VMAT 
plans could be generated without user dependency and trial-
and-error approach. PTV coverage was similar for the 3 
approaches, with on average a V100% of 95.2, 95.4%, and 
94.1% for CK, VMAT-3mm and VMAT-5mm. However, for some 
VMAT plans with 5mm margin, coverage > 95% was not 
feasible. Mean values for rectum D1cc were 26.1, 28.5, and 
34.3 Gy, for rectum Dmean 6.3, 7.1, and 10.8 Gy, for bladder 
D1cc 37.7, 37.3, and 39.4 Gy, and for bladder Dmean 8.7, 
7.5, and 9.2 Gy, for CK, VMAT-3mm and VMAT-5mm, 
respectively. Rectum doses were lower with CK compared to 
VMAT-3mm (p = 0.015 and p = 0.08 for rectum D1cc and 
Dmean) and highly decreased compared to VMAT-5mm (p = 
0.007 and 0.008). Bladder sparing worsened slightly with CK 
compared to VMAT-3mm, but this was not statistically 
significant. No relevant differences were found for other 
OARs. With CK, the low-medium dose bath was reduced 
compared to VMAT: V10Gy = 1157.5, 1525.6, 1741.8 cc, 
V20Gy = 286.3, 325.5, 382.0 cc, for CK, VMAT-3mm and 
VMAT-5mm, respectively, with p = 0.007 and p=0.008 for CK 
comparing to VMAT 3 and 5 mm. 
 
Conclusion: The first system for automated generation of 
clinically deliverable Cyberknife plans was built and used for 
unbiased plan comparison with VMAT at a linac. Optimized 
non-coplanar setups showed better rectum sparing compared 
to VMAT plans. This difference was especially large with the 
smaller CK CTV-PTV margin, possible with CyberKnife tumor 
tracking feature. 
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Purpose or Objective: Recently, iCycle/Monaco, a system for 
fully automated, multi-criterial plan generation, consisting of 
the in-house iCycle optimizer and Monaco (Elekta AB, 
Stockholm, Sweden) has been developed. Sofar, the system 
was only validated in a single institution. In this study, 
iCycle/Monaco was validated in 4 independent centers for 
prostate cancer VMAT. Hypothesis of the study was that 
automatically generated plans had similar or superior quality 
compared to plans generated by manual planning in clinical 
routine, using the Monaco TPS only. 
 
Material and Methods: For each of the 4 centers, plans of 10 
recently treated patients were used to configure 
iCycle/Monaco. For 20 independent patients, manually 
generated VMAT plans (MANplan) were then compared with 
automatically generated VMAT plans (AUTOplan). Plans were 
compared using dose-volume parameters and by ‘blind’ 
scoring by treating physicians. The scoring of the plans by 
physicians was performed in 2 sessions: A) the in total 40 
anonymized plans (20 AUTO, 20 MAN) were evaluated in 
random order to assess clinical acceptability, B) for each of 
the 20 patients, the AUTOplan and MANplan were compared 
to select the most favorable plan. In these comparisons, 
plans could be scored as i) of higher quality with a clinically 
relevant difference, ii) of higher quality but with a low 
clinical impact, or iii) of similar quality. In one participating 
center, plan scoring was performed independently by 2 
physicians. 
Results: A total of 200 separate plan evaluations and 100 
plan comparisons were made in this study. In the separate 
plan evaluations, 100% of MANplans and 98% of AUTOplans 
were clinically acceptable. The 2 AUTOplans that were not 
clinically acceptable had too high bowel dose, which was due 
to the absence of patients with small bowel delineation 
among the patients used for configuration of iCycle/Monaco 
in 2 centers. For 38/100 plan comparisons, the AUTOplan was 
considered superior to the MANplan, with high clinical 
relevance. Only in 9 comparisons, the MANplan was superior 
with high relevance for the patient. In all other comparisons, 
differences were absent or of minor clinical relevance 
(Figure). With similar PTV coverage, dose delivery to OARs 
was on average lower for the AUTOplans: -14.8%, -24.6%, and 
-14.6% for rectum V75, V60, and Dmean (p=0.001, p<0.001, 
p<0.001), and -5.1% for bladder Dmean (p=0.009). 
 
Frequency histogram showing the scores for 100 comparisons 
of an automatically (AUTO) and a manually (MAN) generated 
plan.  
 
Conclusion: In an international, multi-institutional setting, 
automatic planning for prostate cancer has proven to be 
overall superior to manual planning. Automated planning 
avoids planning workload and contributes to standardized 
radiotherapy treatment with high plan quality. 
 
Proffered Papers: RTT 3: Ensuring quality in head and neck 
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Purpose or Objective: Simultaneously integrated boost (SIB) 
used in many sites, replanning is not made. In SIB of 
intensity-modulated radiotherapy (IMRT), doses per fraction 
are often unconventional, because of equal fractions treating 
multiple targets. We assessed sequential SIB (SEQ-SIB) to 
resolve the problem. The purpose of this study is to compare 
dosimetric parameters of SEQ-SIB with those of SIB using 
deformable imaging registration (DIR) for head and neck 
cancer patients. 
 
Material and Methods: Subjects were 10 cases HNC treated 
with IMRT at our institute in 2014. In all cases, high-risk 
planning target volume (PTVboost) was based on the primary 
tumor and clinical lymph node metastases, while 
PTVelective(PTVel) included bilateral cervical nodal areas. 
The D95 was defined as the prescribed dose. For SIB, doses 
were 66 and 54 Gy in 30 fractions to PTVboost and PTVel, 
respectively. For SEQ-SIB, they were 55 Gy to PTVboost and 
50 Gy to PTVel in 25 fractions using SIB, followed by 11 Gy in 
5 fractions to PTVboost.We chose to maintain the size of the 
